全景阅兵ADC，下一棋落子何处
随着FDA批准的ADC药物越来越多，受到鼓舞的开发商们明显地加大了对ADC管线资产的投资力度。ADC正在重新定义靶向癌症治疗的前景。ADC的发展，在抗体、有效载荷和接头的开发设计方面都实现了迭代更新。自从2000年首款ADC药物Mylotarg(ge ...
The need for speed: ADC for efficient AI data management
ADCs offer one strategic point of control through which traffic flows, enabling enterprises to optimize, secure and scale AI ...
EconoTimes1 小时
AstraZeneca Acquires EsoBiotec for $1B to Boost Cell Therapy Innovations
AstraZeneca (NASDAQ:AZN) has announced plans to acquire biotechnology company EsoBiotec for up to $1 billion, aiming to ...
GEN - Genetic Engineering and Biotechnology News18 小时
StockWatch: Will BMS–2seventy Deal Prove a Win-Win?
Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...